| Thank you, Pepsi! |
 |
|
We want to thank Mike Gross and Pepsi for keeping us adequately hydrated with delicious SoBe LifeWater and Aquafina last Sunday.
|
Thanksgiving Day
|
 |
|
Walk with a Doc
supports this wonderful
event, the
Pilgrim's Pride 4-Miler.
Great cause. Great price.
Great event. Great people. Eat Dinner with Nash, Mason, and Commodore at The Lakes CC.
You won't believe it!
Price goes up Nov.1.
Please visit
for more info.
| |
|
Greetings!
Good morning! Truth be told, I'm typing this on Beggar's Night. It is a perfectly lovely evening, not unlike a Norman Rockwell painting. Just sitting here on our front porch handing out samples of organic bean sprouts and a delectable wheat grass shake I just threw together. Surprised to see the amount of spitting and impolite hand gestures from the little ones, though. They grow up so fast. Anyway, it certainly looks to be a lovely weekend...somewhere.
|
 |
Congratulations to our Employee of the Month - Kathryn Stephens! |
 We are proud to announce that our Executive Director, Kathryn Stephens, has been chosen as our October 2009 Employee of the Month. Kathryn achieved this honor through her outstanding work, interpersonal skills, and vision. Congratulations, Kathryn! |
|
This Saturday |
 The medical student leadership of Walk with a (Future) Doc - Ohio State will be taking charge of Highbanks (Big Meadows) this Saturday morning at 8:30. We are very impressed with these young men and women. They are grinding it out at an excellent medical school 24/7 and then leading their own walk on Wednesday nights (6:30).
Our staff will be present, with all the usual breakfast goodies. Please join our group for a rousing good time.
|
|
Two-thirds of Heart Failure Patients are not getting a major drug |
 There are a lot of helpful articles on www.cardiosmart.org - and the one below is a great example. Do you know someone who has heart failure and is not taking an aldosterone antagonist? That person should consider talking with his or her cardiologist about being treated with one. Having two-thirds of patients miss out on a recommended therapy is simply not acceptable.
By Daniel J. DeNoon
WebMD Health News
Reviewed by Elizabeth Klodas, MD, FACC
Oct. 20, 2009 -- More than two-thirds of patients hospitalized with serious heart failure aren't prescribed an aldosterone antagonist, a recommended therapy that increases the odds of survival.
Aldosterone is a hormone that is released in the setting of heart failure. It causes salt and water retention, which can lead to worsening symptoms (such as shortness of breath and leg swelling). Aldosterone antagonists block the action of aldosterone and are a well-recognized part of heart failure treatment.
Published guidelines specifically recommend aldosterone antagonists for patients with moderate-to-severe heart failure. Aldactone and Inspira are the two aldosterone antagonists (AAs) available on the market. They're not for every patient. But the present study shows that far too many patients who should be getting AAs are not.
The finding comes from a survey by Cleveland Clinic researcher Nancy M. Albert, PhD, RN, and colleagues, who followed up on 43,625 AA-eligible heart failure patients released from 241 U.S. hospitals from 2005 through 2007.
"Less than one-third of eligible patients hospitalized for heart failure ... received heart failure guideline-recommended aldosterone antagonist therapy," Albert and colleagues write in the study.
| |
|
Please have a great weekend (with lots of activity). You've earned it.
Best,
David
Walk with a Doc
|
|
|
